skip to Main Content
Novaplex™ Urinary Tract Infection (UTI)
Detection and identification of 18 bacterial targets

In 2007, in the United States alone, there were an estimated 10.5 million office visits for UTI symptoms (constituting 0.9% of all ambulatory visits).1,2


In 2007, UTIs accounted for 2–3 million emergency department visits in the US.1,2

Understanding Urinary Tract Infections

Urinary tract infections (UTIs) are a severe public health problem and are caused by a range of pathogens, most commonly by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis and Staphylococcus saprophyticus. A lower urinary tract infection is known as a bladder infection (cystitis) and the upper urinary tract infection is known pyelonephritis (kidney infection). Symptoms may include pain when urinating, pelvic pain, incontinence, difficulty urinating, frequent urination, having a need to urinate even after recent urination, and fever. Some infections may also be asymptomatic. High rates and antimicrobial resistance greatly increase the need for retesting of these infections.

The Novaplex™ Urinary Tract Infection (UTI) Panel Assays* are multiplex real-time RT-PCR assays that detect and identify 18 UTI causing pathogens simultaneously. 

Product Information

Enterobacter cloacae complex* (ECC)
Escherichia coli (EC)
Klebsiella aerogenes (KA)
Klebsiella oxytoca (KO)
Klebsiella pneumoniae (KP)
Pseudomonas aeruginosa (PA)
Proteus mirabilis (PM)
Proteus vulgaris (PV)
Serratia marcescens (SM)

* incl. E. cloacae, E. asburiae, E. hormaechei, E. kobei, and E. ludwigii

Enterococcus faecium (Efm)
Staphylococcus saprophyticus (SS)
Candida others** (CO)
Staphylococcus epidermidis (SE)
Enterococcus faecalis (Efs)
Staphylococcus aureus (SA)
Candida albicans (CA)
Streptococcus agalactiae (GBS)

**Candida others: Candida glabrata (CG), Candida tropicalis (CT), Candida parapsilosis (CP), Candida krusei (CK)
Actinobaculum schaalii (AS)

Acinetobacter baumannii (AB)
Aerococcus urinae (AU)
Citrobacter freundii (CF)
Citrobacter koseri (CK)
Corynebacterium urealyticum (CU)
Morganella morganii (MM)
Pantoea agglomerans (Pag)
Providencia stuartii (PS)
Streptococcus anginosus (San)


Urine sample

Compatible instrumentation

Automated Extraction & PCR Setup
Seegene NIMBUS
Seegene STARlet

Real-time PCR

CFX96™ Real-time PCR System (Bio-Rad)
CFX96™ Dx System (Bio-Rad)
CFX96™ Opus (Bio-Rad)
CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad)

Seegene Viewer Software

  • Quick and easy data analysis and interpretation
  • Interface specialized for multiplex testing
Key Features
  • Multiplex real-time PCR- Simultaneous detection and identification of urinary tract pathogens 
  • Short TAT- 4 hours from extraction to final result
  • Multi-Ct in a single channel- Individual Ct value of multiple analytes in a single channel of real-time PCR instrument (MuDT™ Technology)
  • Cost-effective testing- Allows detection of urinary pathogens in a single test
Ordering Information

Select the assays you are interested in and a Seegene representative will contact you to complete your order.


Robin Patel, Christopher R Polage, Jennifer Dien Bard, Larissa May, Francesca M Lee, Valeria Fabre, Mary K Hayden, Sarah D B Doernberg, David A Haake, Barbara W Trautner, Larissa Grigoryan, Ephraim L Tsalik, Kimberly E Hanson, on behalf of the Antibacterial Resistance Leadership Group and the Infectious Diseases Society of America, Envisioning Future Urinary Tract Infection Diagnostics, Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1284–1292

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015 May;13(5):269-84. doi: 10.1038/nrmicro3432. Epub 2015 Apr 8. PMID: 25853778; PMCID: PMC4457377.

1 Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 2011;13:1–38. [PubMed ID 21614897]
2 Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28:1–13. This paper presents the most recent information about UTIs and their socioeconomic impact. [PMID: 24484571]
Back To Top